Drug Patenting in India: Potentially Lucrative, but a Difficult Task
January 8, 2010
Foley Partner George Best and Associate Photon Rao authored an article titled “Drug Patenting in India: Potentially Lucrative, but a Difficult Task” in the January 8, 2010 issue of BNA’s Pharmaceutical Law & Industry Report.
Reproduced with permission from Pharmaceutical Law & Industry Report, 8 PLIR 46, 01/08/2010. Copyright 2010 by The Bureau of National Affairs, Inc. (800-372-1033) http://www.bna.com
Related Insights
January 2, 2026
Manufacturing Industry Advisor
Federal Court Denies Claim that Franchisor Is a Joint Employer with Franchisee
A federal court recently dismissed employment discrimination claims against a franchisor asserted by its franchisees’ employee after…
December 29, 2025
Tariff & International Trade Resource
Mexican January 2026 Tariff Tsunami: Maquilas Aren’t Immune
On January 1, 2026, Mexico will increase its general import tariff rate (known as the most favored nation (MFN) rate). The increase will be in the range of five to fifty percent, impacting 1,463 eight-digit tariff lines encompassing thousands of products originating in countries with which Mexico does not have a free trade agreement (FTA or the measure).
December 24, 2025
Health Care Law Today
Gender-Affirming Care: Multi‑State Lawsuit Challenges HHS Declaration
As previously discussed in Foley’s healthcarelawtoday, on December 18, 2025, the U.S. Department of Health & Human Services (HHS) held a press conference focused on what it defined as “sex rejection procedures” (SRPs), also known as gender-affirming care (GAC) for minors, and outlined next steps.